Graypoint LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,109
| Closed | -$439K | – | 525 |
|
|
2024
Q4 | $439K | Sell |
5,109
-1,025
| -17% | -$88.2K | 0.03% | 333 |
|
|
2024
Q3 | $730K | Sell |
6,134
-381
| -6% | -$45.4K | 0.05% | 236 |
|
|
2024
Q2 | $930K | Buy |
6,515
+2,091
| +47% | +$298K | 0.06% | 187 |
|
|
2024
Q1 | $568K | Buy |
4,424
+582
| +15% | +$74.7K | 0.04% | 255 |
|
|
2023
Q4 | $397K | Buy |
3,842
+342
| +10% | +$35.4K | 0.03% | 296 |
|
|
2023
Q3 | $318K | Buy |
+3,500
| New | +$318K | 0.03% | 317 |
|